Ftivazide
Based on 1 Customer Validation
Ftivazide has anti-tuberculosis activity.
For research use only. We do not sell to patients.
- Purity: 99.9%
- CAS No.: 149-17-7
- Formula: C14H13N3O3
- Molecular Weight:271.27
-
Storage:Powder -20°C, 3 years ; In solvent -80°C, 6 months , -20°C, 1 month
Biological Activity
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| HEL | EC50 |
>100 μg/mL
Compound: 2
|
Antiviral activity against Human herpesvirus 1 strain KOS infected in human HEL cells assessed as inhibition of virus-induced cytopathicity
Antiviral activity against Human herpesvirus 1 strain KOS infected in human HEL cells assessed as inhibition of virus-induced cytopathicity
|
10.1007/s00044-011-9662-9 |
| HEL | EC50 |
>100 μg/mL
Compound: 2
|
Antiviral activity against Human herpesvirus 2 strain G infected human HEL cells assessed as inhibition of virus-induced cytopathicity
Antiviral activity against Human herpesvirus 2 strain G infected human HEL cells assessed as inhibition of virus-induced cytopathicity
|
10.1007/s00044-011-9662-9 |
| HEL | EC50 |
>100 μg/mL
Compound: 2
|
Antiviral activity against TK(-) aciclovir-resistant Human herpesvirus 1 strain KOS infected in human HEL cells assessed as inhibition of virus-induced cytopathicity
Antiviral activity against TK(-) aciclovir-resistant Human herpesvirus 1 strain KOS infected in human HEL cells assessed as inhibition of virus-induced cytopathicity
|
10.1007/s00044-011-9662-9 |
| HEL | EC50 |
>100 μg/mL
Compound: 2
|
Antiviral activity against Vaccinia virus infected human HEL cells assessed as inhibition of virus-induced cytopathicity
Antiviral activity against Vaccinia virus infected human HEL cells assessed as inhibition of virus-induced cytopathicity
|
10.1007/s00044-011-9662-9 |
| HeLa | EC50 |
>20 μg/mL
Compound: 2
|
Antiviral activity against Human coxsackievirus B4 infected human HeLa cells assessed as inhibition of virus-induced cytopathicity
Antiviral activity against Human coxsackievirus B4 infected human HeLa cells assessed as inhibition of virus-induced cytopathicity
|
10.1007/s00044-011-9662-9 |
| HeLa | EC50 |
>20 μg/mL
Compound: 2
|
Antiviral activity against Respiratory syncytial virus infected human HeLa cells assessed as inhibition of virus-induced cytopathicity
Antiviral activity against Respiratory syncytial virus infected human HeLa cells assessed as inhibition of virus-induced cytopathicity
|
10.1007/s00044-011-9662-9 |
| HeLa | EC50 |
>20 μg/mL
Compound: 2
|
Antiviral activity against Vesicular stomatitis virus infected human HeLa cells assessed as inhibition of virus-induced cytopathicity
Antiviral activity against Vesicular stomatitis virus infected human HeLa cells assessed as inhibition of virus-induced cytopathicity
|
10.1007/s00044-011-9662-9 |
| MT4 | CC50 |
>=89 μg/mL
Compound: 2
|
Cytotoxicity against Homo sapiens (human) MT4 cells
Cytotoxicity against Homo sapiens (human) MT4 cells
|
10.1007/s00044-011-9662-9 |
| MT4 | EC50 |
>89 μg/mL
Compound: 2
|
Antiviral activity against Human immunodeficiency virus 1 IIIB infected human MT4 cells assessed as inhibition of virus-induced cytopathicity
Antiviral activity against Human immunodeficiency virus 1 IIIB infected human MT4 cells assessed as inhibition of virus-induced cytopathicity
|
10.1007/s00044-011-9662-9 |
| MT4 | EC50 |
>89 μg/mL
Compound: 2
|
Antiviral activity against Human immunodeficiency virus type 2 (ISOLATE ROD) infected human MT4 cells assessed as inhibition of virus-induced cytopathicity
Antiviral activity against Human immunodeficiency virus type 2 (ISOLATE ROD) infected human MT4 cells assessed as inhibition of virus-induced cytopathicity
|
10.1007/s00044-011-9662-9 |
| Vero | EC50 |
>100 μg/mL
Compound: 2
|
Antiviral activity against Human coxsackievirus B4 infected Vero cells assessed as inhibition of virus-induced cytopathicity
Antiviral activity against Human coxsackievirus B4 infected Vero cells assessed as inhibition of virus-induced cytopathicity
|
10.1007/s00044-011-9662-9 |
| Vero | EC50 |
>100 μg/mL
Compound: 2
|
Antiviral activity against Human parainfluenza virus 3 infected Vero cells assessed as inhibition of virus-induced cytopathicity
Antiviral activity against Human parainfluenza virus 3 infected Vero cells assessed as inhibition of virus-induced cytopathicity
|
10.1007/s00044-011-9662-9 |
| Vero | EC50 |
>100 μg/mL
Compound: 2
|
Antiviral activity against Mammalian orthoreovirus 1 infected Vero cells assessed as inhibition of virus-induced cytopathicity
Antiviral activity against Mammalian orthoreovirus 1 infected Vero cells assessed as inhibition of virus-induced cytopathicity
|
10.1007/s00044-011-9662-9 |
| Vero | EC50 |
>100 μg/mL
Compound: 2
|
Antiviral activity against Punta Toro virus infected Vero cells assessed as inhibition of virus-induced cytopathicity
Antiviral activity against Punta Toro virus infected Vero cells assessed as inhibition of virus-induced cytopathicity
|
10.1007/s00044-011-9662-9 |
| Vero | EC50 |
>100 μg/mL
Compound: 2
|
Antiviral activity against Sindbis virus infected Vero cells assessed as inhibition of virus-induced cytopathicity
Antiviral activity against Sindbis virus infected Vero cells assessed as inhibition of virus-induced cytopathicity
|
10.1007/s00044-011-9662-9 |
Chemical Information
-
CAS No. 149-17-7
-
Appearance Solid
-
Molecular Weight 271.27
-
Formula C14H13N3O3
-
Color White to off-white
-
SMILES
O=C(C1=CC=NC=C1)N/N=C/C2=CC(OC)=C(C=C2)O
-
Synonyms
Phthivazide
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Powder -20°C 3 years In solvent -80°C 6 months -20°C 1 month
Purity & Documentation
-
Data Sheet (264 KB)
-
SDS (393 KB)
- English - EN (393 KB)
- Français - FR (393 KB)
- Deutsch - DE (393 KB)
- Norwegian - NO (393 KB)
- Español - ES (393 KB)
- Swedish - SV (393 KB)
- Italian - IT (393 KB)
- Korean - KR (393 KB)
- Portuguese - PT (393 KB)
-
Handling Instructions (2659 KB)
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)